home / stock / anpcy / anpcy quote
Last: | $1.89 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $1.89 |
High: | $0 |
Low: | $0 |
Volume: | 1 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.89 | $0 | $1.89 | $0 | $0 | 1 | 04-29-2024 |
$1.89 | $0 | $1.89 | $0 | $0 | 2 | 04-24-2024 |
$1.89 | $0 | $1.89 | $0 | $0 | 7 | 04-22-2024 |
$1.89 | $0 | $1.89 | $0 | $0 | 62 | 04-18-2024 |
$1.89 | $0 | $1.89 | $0 | $0 | 33 | 04-15-2024 |
$1.89 | $1.89 | $1.89 | $1.89 | $1.89 | 409 | 04-10-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 60 | 04-08-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 6 | 04-05-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 1 | 04-02-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 12 | 04-01-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 1 | 03-28-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 1 | 03-27-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 9 | 03-26-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 2 | 03-25-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 11 | 03-22-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 15 | 03-20-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 33 | 03-19-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 56 | 03-15-2024 |
$1.8 | $0 | $1.8 | $0 | $0 | 36 | 03-13-2024 |
$1.8 | $1.8 | $1.8 | $1.8 | $1.8 | 145 | 03-12-2024 |
News, Short Squeeze, Breakout and More Instantly...
Angle Plc Surrey ADR Company Name:
ANPCY Stock Symbol:
OTCMKTS Market:
ANGLE commissioned to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies GUILDFORD, SURREY / ACCESSWIRE / May 3, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions...
ANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical R&D GUILDFORD, SURREY / ACCESSWIRE / April 24, 2024 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutio...
Proprietary cell recovery device and method eliminates over 70% of CTC cell loss from standard microscopy techniques increasing assay sensitivity GUILDFORD, SURREY / ACCESSWIRE / April 22, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circula...